NCT02158507 2026-01-22Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast CancerUniversity of Alabama at BirminghamPhase NA Completed20 enrolled 10 charts